https://www.samsaratherapeutics.com/
Samsara Therapeutics Inc. is a platform company engaged in the discovery and development of compounds that address the primary molecular causes of disease initiation and progression. It was built around the world’s largest and most technically sophisticated drug screening platform that was designed specifically to identify new molecules that extend healthy lifespan.
Samsara is anchoring its research on the hallmarks of aging in collaboration with world-leading academic scientists in the fields of energy metabolism and proteostasis.
Most of the known lifespan prolonging molecules such as rapamycin, metformin or resveratrol, act as caloric restriction mimetics (CRM). We combine intellectual property derived from world leading researchers in the field of aging and the state-of-the-art geroprotectors screening platform in order to develop first-in-class CRM molecules for the treatment of age-related diseases by targeting the fundamental hallmarks of aging, including proteostasis, autophagy, and energy metabolism.
